Institute for International Research

Exhibit and Poster Hall Hours
Monday, February 23 · 3:15 pm - 6:45 pm
Tuesday, February 24 · 10:15 am - 3:45 pm
Wednesday, February 25 · Closed

"What makes TIDES so special is going to a conference where you learn about research and clinical updates before anyone else, and meet 'key players' in the field. The workshop and main session are first class. I look forward to participating in this fine event in the years to come. "
- Masad J. Damha, Ph.D., F.C.I.C., James McGill Professor of Chemistry, McGill University, Canada

TIDES Oligonucleotide and Peptide® Technology and Product Development Conference has been held 19 times—10 in the US and 9 in Europe. TIDES is the only conference to focus on technology and product development, manufacturing and partnering in the fields of oligonucleotide- and peptide-based therapeutics and diagnostics. By attending, you will learn how to plan, develop and manufacture your company's candidate. Approximately 750 attendees, speakers and exhibitors from around the world networked and learned at TIDES® 2008 in the US.

AsiaTIDES offers an agenda developed for Japanese and Asian pharmaceutical researchers and executives, as well as for academic scientists. Take advantage of the opportunity to learn how to move your programs to the later stages of development. In addition, hear updates from the most advanced companies around the world which allows you to benchmark research and development in RNAi and other oligonucleotide- and peptide-based programs.

Attendees will receive access to the online partnering system. This community allows you to contact other attendees and set up meetings in advance of the conference. Register now to learn how to advance your research, build your network of partners and collaborators, as well as grow your company's development program and your career.

Keynote Presentations
	Yoshikazu Nakamura, Ph.D. University of Tokyo; Ribomic Japan		Akira Yamada, Ph.D. Kurume University Research Center for Innovative Cancer Therapy Japan
	Junichi Yano, Ph.D. Nippon Shinyaku Co., Ltd. Japan		Takumi Kawabe, M.D., Ph.D. CanBas Japan
Featured Presentations
	Larry Gold, Ph.D. SomaLogic, Inc. USA		Rachel Meyers, Ph.D. Alnylam Pharmaceuticals USA

"AsiaTIDES: A first-of-its-kind meeting in Asia providing valuable insight into this niche area."
- Philip R. Oldfield, Ph.D., Scientific Director, Immunochemistry, Laboratory Sciences, Charles River Laboratories PCS-MTL, Canada

"The concentration of key industry players at TIDES is fantastic; the event is tremendously useful… Almost all the important decision-makers attended TIDES 2008."
- Simon May, Ph.D., Global Director, Business-to-Business Sales, Life Science Research, Thermo Fisher Scientific, United Kingdom

Attendees Praise the U.S. TIDES Conference

"The conference brought nearly all the experts in oligonucleotide therapeutics area under one roof, which made for an educational and entertaining meeting."
- Sumit Lutara, Senior Scientist, Pfizer, Inc, USA

"TIDES conferences in Europe and USA are always great places to learn about all the different aspects of oligonucleotide manufacturing, new diagnostic and therapeutic applications and ideal venues to network with colleagues and customers. I am excited that this great event now also starts in Asia."
- Peter Haima, Ph.D., Manager IVD Services, Eurogentec S.A., Belgium

"I have participated in TIDES since its inception and find it to be by far the most useful meeting in the field, for both the latest updates on drug development and regulatory issues, and also for networking with industry leaders."
- Michael S. Verlander, D. Phil., Executive Vice President, PolyPeptide Laboratories, Inc., USA and India

About the Organizers
This event is brought to you by the organizers of TIDES Peptide and Oligonucleotide® Technology and Product Development and EuroTIDES conferences, as well as Drug Discovery and Development of Innovative Therapeutics World Congress in Boston and Japan, IBC Life Sciences, an informa business. Other informa businesses include: Datamonitor, MedTRACK, SCRIP and Pharmaprojects. www.IBCLifeSciences.com and www.informa.com

Conference Language
The conference will be conducted in English without translation.